Regenerative Kits for Licensed Clinics

Precision-engineered solutions for clinics at the forefront of regenerative medicine. LifeForce Biotech delivers fully integrated PRP-RPC kits for the clinical practitioner.

PRP-RPC kits

Each PRP-RPC kit includes ten FDA compliant PRF tubes (without gel), IV start, and the necessary syringes and needles for sterile processing of the PRP-RPC. Included with each four kit package are the following solutions: anticoagulant (ACD-A), local anesthetic (Ropivacaine), and the crystalloids of dextrose (D50), magnesium sulfate, potassium chloride, and sterile saline.

PRP-RPC Kit Training

Our online training program is designed to quickly and effectively prepare your team to deliver advanced PRP-RPC therapies with confidence. Comprehensive foundational virtual training is included with the initial purchase of four PRP-RPC kits.

Optional In-Person Intensive (1 day): Hands-on training and guided treatment for up to three practitioners, held in Aspen or Basalt, Colorado. (The training fee includes ongoing clinical support to ensure continued success and optimization of your protocols).

If interested in in-person training, contact us at info@lifeforcebiotech.com

*Practitioners who consistently utilize PRP-RPC kits will be licensed and protected under U.S. patent law per under U.S. patent 10130657B2. 

Disclaimer: With increased utilization of platelet-rich plasma (PRP), it is important for clinicians to understand the United States, the Food and Drug Administration (FDA) regulatory role and stance on PRP. Blood products such as PRP fall under the purview of FDA's Center for Biologics Evaluation and Research (CBER). CBER is responsible for regulating human cells, tissues, and cellular and tissue-based products. The regulatory process for these products is described in the FDA's 21 CFR 1271 of the Code of Regulations. Under these regulations, certain products including blood products such as PRP are exempt and therefore do not follow the FDA's traditional regulatory pathway that includes animal studies and clinical trials. The 510(k) application is the pathway used to bring PRP preparation systems to the market. The 510(k) application allows devices that are "substantially equivalent" to a currently marketed device to come to the market. There are numerous PRP preparation systems on the market today with FDA clearance; however, nearly all of these systems have 510(k) clearance for producing platelet-rich preparations intended to be used to mix with bone graft materials to enhance bone graft handling properties in orthopedic practices. The use of PRP outside this setting, for example, an office injection, would be considered "off label." Clinicians are free to use a product off-label as long as certain responsibilities are met. Per CBER, when the intent is the practice of medicine, clinicians "have the responsibility to be well informed about the product, to base its use on firm scientific rationale and on sound medical evidence, and to maintain records of the product's use and effects." https://pubmed.ncbi.nlm.nih.gov/25268794/